ArticlePloS one2015

Impact of IL28B, APOH and ITPA Polymorphisms on Efficacy and Safety of TVR- or BOC-Based Triple Therapy in Treatment-Experienced HCV-1 Patients with Compensated Cirrhosis from the ANRS CO20-CUPIC Study.

Frédégonde About et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.